Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- 17 Types of Advanced Medical Technology Approved
November 8, 2004
- OTC NEWS IN BRIEF
November 8, 2004
- Urgent Listing for Valixa Tab Approved
November 8, 2004
- Press Seminar
November 8, 2004
- Semi-annual Business Results
November 8, 2004
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
November 8, 2004
- Business Forecast
November 8, 2004
- Postoperative Adjuvant Therapy Recommended as Grade A Standard for Lung Cancer: JLCS
November 8, 2004
- BUSINESS NEWS IN BRIEF
November 8, 2004
- GL on Clinical Evaluation of Anti-Malignant Tumor Agents Revised
November 8, 2004
- Degussa Japan Opens New Pharmapolymers Technical Center
November 8, 2004
- Length of Clinical Trials Averages 555 Days: JPMA
November 8, 2004
- Price Negotiations Proceeding More Quickly This Year: Kraft
November 8, 2004
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
November 8, 2004
- BULLETIN
November 8, 2004
- Korosho to Build Up Core Hospital Network to Collect ADR Reports
November 8, 2004
- Importance of Alliance Increases for Domestic Companies: OPIR Report
November 8, 2004
- PMDA to Fund Regional Clinical Trial Network Project
November 8, 2004
- Mediceo Group Plans to Strengthen Healthcare Division
November 8, 2004
- Pharmacists Have Responsibility to Be "Drug Pros": Seminar
November 8, 2004
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…